Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001382963-15-000059
Filing Date
2015-06-24
Accepted
2015-06-24 21:22:48
Documents
2
Period of Report
2015-06-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 8183
2 poadoy.htm EX-24 2894
  Complete submission text file 0001382963-15-000059.txt   12474
Mailing Address 1801 CENTURY PARK EAST, SUITE 1820 LOS ANGELES CA 90067
Business Address 1801 CENTURY PARK EAST, SUITE 1820 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Issuer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RITTER PHARMACEUTICALS INC. 1801 CENTURY PARK EAST, SUITE 1820 LOS ANGELES CA 90096
Business Address
Doyle Noah (Reporting) CIK: 0001631673 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37428 | Film No.: 15950475